Professionals 304 results
Capabilities 75 results
Practice Area
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Practice Area
Representation & Warranty Insurance Claims
Experience 60 results
Experience
|March 4, 2026
End of the Line: Winston Wins Unanimous Supreme Court Victory Against NJ Transit
Experience
|January 27, 2026
Experience
|September 8, 2025
Insights & News 2,403 results
Non-Fungible Insights: Blockchain Decrypted
|March 13, 2026
|7 Min Read
The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
In the Media
|March 4, 2026
|1 Min Read
Suzanne Labi Discusses Current State of UK Class Actions with the Law Society Gazette
Other Results 52 results
Law Glossary
What Is Advertising Litigation?
Law Glossary
What Is Consumer Marketing Law?
Site Content
What Is the National Advertising Division (NAD)?


